Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2023-01-06 00:00:00 ET · period of report 2022-07-01 · accession 0001209191-23-002412 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-01-06 | 2022-07-01+ | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $37.65 | -2,028 | 16.2K | -11% | -$76.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-03 | S | D | 231 | $34.48 | 16,165 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-04 | S | D | 1,692 | $37.21 | 14,473 | D | — | — | |
| 3 | Common | Common Stock | 2022-07-01 | S | D | 105 | $51.74 | 16,165 | D | — | — |